About us

History

2009

Founding of new curasan Inc, the US subsidiary to focus on the orthopedic, spine, and trauma market
Transfer of curasan AG stock from Prime Standard to General Standard

2008
Sale of dental division to RIEMSER ARZNEIMITTEL AG
Re-structuring to maximize opportunity in in the orthopedic market
Awarded Japanese patent for Cerasorb® M.

2007
FDA clearance for its REVOIS® All-in-One dental implant system
Granted worldwide distribution rights for Epi-Guide®, a bioresorbable membrane.

2006
Received DIN EN ISO 13485:2003 Medical Devices - Quality Management Systems - certification
International product launch REVOIS® All-in-One Dental Implant System

2005
International product launch Curavisc®, a natural hyaluronic acid for the treatment of osteoarthritis
Publication of the prospective, randomised multi-centre study proving that Cerasorb® synthetic bone regeneration material, equals autogenous bone

2004
founding of US subsidiary curasan, Inc. focussing on dental applications
International product launch of Cerasorb® M with a porosity of 65%
Merging of GerontoCare and Titanium Innovations GmbH with curasan AG

2003
Product launch of Cerasorb® Ortho™ in the USA
FDA-approval of Cerasorb® block forms in the USA
FDA-certification of Cerasorb® production site
Sale of pharmaceuticals business

2002
FDA-approval for Cerasorb® Ortho™ for use in orthopedics and traumatology
CE-approval for Cerasorb® block forms

2001
acquisition of Titanium Innovations
acquisition of Pro-tec Medizinische Produkte GmbH
launch of stypro®
upgrading of R&D and production center in Frankfurt

2000
Innovation Award for Cerasorb®
transformation into a public company (curasan AG) and Initial Public Offering (IPO)

1999
first clinical results on Cerasorb®
founding of curasan branch in France
launch of a method for the production of platelet rich plasma (PRP) from patient own blood

1998
start of clinical studies with Cerasorb®
launch of Hy-GAG®
founding of liaison office Austria

1997
registration of Cerasorb® for dentistry and maxillofacial surgery

1996
founding of curasan® Benelux

1988
founding of curasan® Pharma GmbH
launch of local anaesthetics
market introduction of antibiotics